Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code

LIU Dianhua, ZHANG Enhui, LIU Chong, FAN Boshi, CAI Guojun. Signaling pathway of acetylcholine receptors in atherosclerosis induced by nicotinic[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(2): 81-84. doi: 10.3969/j.issn.1006-0111.2014.02.001
Citation: LIU Dianhua, ZHANG Enhui, LIU Chong, FAN Boshi, CAI Guojun. Signaling pathway of acetylcholine receptors in atherosclerosis induced by nicotinic[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(2): 81-84. doi: 10.3969/j.issn.1006-0111.2014.02.001

Signaling pathway of acetylcholine receptors in atherosclerosis induced by nicotinic

doi: 10.3969/j.issn.1006-0111.2014.02.001
  • Received Date: 2013-07-28
  • Rev Recd Date: 2013-10-14
  • Objective Atherosclerosis is an inflammatory disease in the vessel wall. Nicotine, a major component of cigarette smoke, is an independent risk factor for cardiovascular diseases including atherosclerosis. Recent studies have shown that nicotine (the addictive component of cigarettes) binds to high affinity cell-surface receptors and accelerates the atherogenic process. These receptors were called nicotinic acetylcholine receptors (nAChR) and expressed ubiquitously in almost all cells existing in the blood vessels. Therefore, the pro-atherogenic effects of nAChR pathway ligands were summarized which would enhance the understanding of the role of nicotine and nAChR in the pathophysiology of atherosclerosis. The signaling pathways underlying nAChR subunits in cells were described that play an important role in atherosclerosis, i.e. VSMCs, endothelial cells, platelets and immune cells. How these pathways converge on the growth and survival of atheromatous plaques were also discussed. Finally, the feasibility of nAChR ligands as therapeutic targets for atherosclerosis was summarized.
  • [1] Stylianou IM, Bauer RC, Reilly MP, et al. Genetic basis of atherosclerosis:Insights from mice and humans[J].Circ Res, 2012,110(2):337-355.
    [2] Doyle B, Caplice N. Plaque neovascularization and antiangiogenic therapy for atherosclerosis[J].J Am Coll Cardiol, 2007,49(21):2073-2080.
    [3] Unverdorben M, von Holt K, Winkelmann BR. Smoking and atherosclerotic cardiovascular disease:PartⅡ:role of cigarette smoking in cardiovascular disease development[J].Biomark Med, 2009,3(5):617-653.
    [4] Santanam N, Thornhill BA, Lau JK, et al. Nicotinic acetylcholine receptor signaling in atherogenesis[J].Atherosclerosis, 2012;225:264-273.
    [5] Egleton RD, Brown KC, Dasgupta P. Angiogenic activity of nicotinic acetylcholine receptors:implications in tobacco-related vascular diseases[J].Pharmacol Ther, 2009,121(2):205-223.
    [6] Ulloa L. The vagus nerve and the nicotine anti-inflammatory pathway[J].Nat Rev, 2005,4:673-684.
    [7] Cucina A, Fuso A, Coluccia P, et al. Nicotine inhibits apoptosis and stimulates proliferation in aortic smooth muscle cells through a functional nicotinic acetylcholine receptor[J].J Surg Res, 2008,150(2):227-235.
    [8] Strohschneider T, Oberhoff M, Hanke H, et al. Effect of chronic nicotine delivery on the proliferation rate of endothelial and smooth muscle cells in experimentally induced vascular wall plaques[J].Clin Invest, 1994,72(11):908-912.
    [9] Heeschen C, Jang JJ, Weis M, et al. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis[J].Nat Med, 2001,7(7):833-839.
    [10] Lau PP, Li L, Merched AJ, Zhang AL, et al. Nicotine induces proinflammatory responses in macrophages and the aorta leading to acceleration of atherosclerosis in low-density lipoprotein receptor(-/-) mice[J].Arterioscler Thromb Vasc Biol, 2006,26(1):143-149.
    [11] Thorgeirsson TE, Geller F, Sulem P, et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial diseas[J].Nature, 2008,452(7187):638-642.
    [12] Wang Z, Wu W, et al. NF-ΚB pathway mediates vascular smooth muscle response to nicotine[J].Int J Biochem Cell Biol, 2012,45 (2):375-383.
    [13] Chan SM, Ermann J, Su L, et al. Protein microarrays for multiplex analysis of signal transduction pathways[J].Nat Med, 2004,10(12),1390-1396.
    [14] Wu JC, Chruscinski A, De Jesus Perez VA, et al. Cholinergic modulation of angiogenesis:role of the 7 nicotinic acetylcholine receptor[J].J Cell Biochem, 2009, 108(2):433-446.
    [15] Kanda Y, Watanabe Y. Nicotine-induced vascular endothelial growth factor release via the egfrerk pathway in rat vascular smooth muscle cells[J].Life Sci, 2007, 80(15):1409-1414.
    [16] Bucerius J, Manka C, Schmaljohann J, et al. Feasibility of [18F]-2-fluuoro-A85380-PET imaging of human vascular nicotinic acetylcholine receptors in vivo[J].JACC Cardiovasc Imaging, 2012,5(5):528-536.
    [17] Cooke JP. Imaging vascular nicotine receptors:a new window onto vascular disease[J].JACC Cardiovasc Imaging, 2012,5(5):537-539.
    [18] Zhang G, Marshall AL, Thomas AL, et al. In vivo knockdown of nicotinic acetylcholine receptor alpha1 diminishes aortic atherosclerosis[J].Atherosclerosis, 2011,215(1):34-42.
    [19] Li S, Zhao T, Xin H, et al. Nicotinic acetylcholine receptor alpha7 subunit mediates migration of vascular smooth muscle cells toward nicotine[J].J Pharmacol Sci, 2004,94(3):334-338.
    [20] Cooke JP, Ghebremariam YT. Endothelial nicotinic acetylcholine receptors and angiogenesis[J].Trends Cardiovas Med, 2008, 18(7):247-253.
  • 加载中
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Article Metrics

Article views(3003) PDF downloads(81) Cited by()

Related
Proportional views

Signaling pathway of acetylcholine receptors in atherosclerosis induced by nicotinic

doi: 10.3969/j.issn.1006-0111.2014.02.001

Abstract: Objective Atherosclerosis is an inflammatory disease in the vessel wall. Nicotine, a major component of cigarette smoke, is an independent risk factor for cardiovascular diseases including atherosclerosis. Recent studies have shown that nicotine (the addictive component of cigarettes) binds to high affinity cell-surface receptors and accelerates the atherogenic process. These receptors were called nicotinic acetylcholine receptors (nAChR) and expressed ubiquitously in almost all cells existing in the blood vessels. Therefore, the pro-atherogenic effects of nAChR pathway ligands were summarized which would enhance the understanding of the role of nicotine and nAChR in the pathophysiology of atherosclerosis. The signaling pathways underlying nAChR subunits in cells were described that play an important role in atherosclerosis, i.e. VSMCs, endothelial cells, platelets and immune cells. How these pathways converge on the growth and survival of atheromatous plaques were also discussed. Finally, the feasibility of nAChR ligands as therapeutic targets for atherosclerosis was summarized.

LIU Dianhua, ZHANG Enhui, LIU Chong, FAN Boshi, CAI Guojun. Signaling pathway of acetylcholine receptors in atherosclerosis induced by nicotinic[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(2): 81-84. doi: 10.3969/j.issn.1006-0111.2014.02.001
Citation: LIU Dianhua, ZHANG Enhui, LIU Chong, FAN Boshi, CAI Guojun. Signaling pathway of acetylcholine receptors in atherosclerosis induced by nicotinic[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(2): 81-84. doi: 10.3969/j.issn.1006-0111.2014.02.001
Reference (20)

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return